BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35678121)

  • 1. Single-cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases.
    Ruan H; Wang Z; Sun Z; Wei J; Zhang L; Ju H; Wang T; Zhang C; Guan M; Pan S
    Clin Transl Med; 2022 Jun; 12(6):e885. PubMed ID: 35678121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single-cell transcriptome analysis.
    Ruan H; Zhou Y; Shen J; Zhai Y; Xu Y; Pi L; Huang R; Chen K; Li X; Ma W; Wu Z; Deng X; Wang X; Zhang C; Guan M
    Clin Transl Med; 2020 Dec; 10(8):e246. PubMed ID: 33377642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.
    Ying S; Ke H; Ding Y; Liu Y; Tang X; Yang D; Li M; Liu J; Yu B; Xiang J; Mao X; Han-Zhang H; Hu W; Chen L
    Cancer Biol Ther; 2019; 20(4):562-570. PubMed ID: 30395779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
    Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
    J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
    Yang H; Wen L; Pan Y; Shan C; Hong W; Wang H; Zhou C; Cai L; Zhou C
    BMC Cancer; 2022 May; 22(1):580. PubMed ID: 35614407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
    Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
    J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis.
    Huang R; Ge M; Zhou X; Ji X; Liao L; Liang X; Zhan Q
    Cancer Biother Radiopharm; 2019 Mar; 34(2):128-133. PubMed ID: 30452286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
    Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E
    J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.
    Miao Q; Zheng X; Li L; Zheng X; Zhang L; Jiang K; Wu S; Wang H; Wu B; Xu Y; Zhong Q; Zou Z; Zhang Q; Yang S; Li Y; Lin G
    J Neurooncol; 2023 Dec; 165(3):517-525. PubMed ID: 38104049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.
    Cordone I; Masi S; Summa V; Carosi M; Vidiri A; Fabi A; Pasquale A; Conti L; Rosito I; Carapella CM; Villani V; Pace A
    Breast Cancer Res; 2017 Apr; 19(1):46. PubMed ID: 28399903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer.
    Wang Y; Luo N; Gao Y; Wu Y; Qin X; Qi Y; Sun T; Tao R; Qi C; Liu B; Yuan S
    J Cancer Res Clin Oncol; 2023 May; 149(5):1679-1690. PubMed ID: 35583828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular detection of human mammaglobin in cerebrospinal fluid from breast cancer patient with leptomeningeal carcinomatosis.
    Dono M; Ferro P; Benedetti L; Capellini C; Moroni M; Dessanti P; Bacigalupo B; Tartaglione A; Battolla E; Fedeli F; Roncella S
    J Neurooncol; 2009 Feb; 91(3):295-8. PubMed ID: 18841443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer.
    Nevel KS; DiStefano N; Lin X; Skakodub A; Ogilvie SQ; Reiner AS; Pentsova E; Boire A
    Neuro Oncol; 2020 May; 22(5):675-683. PubMed ID: 32352148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer.
    Chen X; Bai K; Zhang Y; Xu Y; Huo Y; Wang S; Zou Y; Qi X; Guo R; Ou Q; Liu D; Yin S; Chen S; Bu H
    J Transl Med; 2023 May; 21(1):296. PubMed ID: 37131253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
    Lin Y; Li H; Huang M; Yin Z; Wu J
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
    Lin Y; Yu T; Li H; Yin Z; Guo A
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
    Li YS; Jiang BY; Yang JJ; Zhang XC; Zhang Z; Ye JY; Zhong WZ; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Du HJ; Chuai S; Han-Zhang H; Su J; Zhou Q; Yang XN; Guo WB; Yan HH; Liu YH; Yan LX; Huang B; Zheng MM; Wu YL
    Ann Oncol; 2018 Apr; 29(4):945-952. PubMed ID: 29346604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study.
    Darlix A; Cayrefourcq L; Pouderoux S; Menjot de Champfleur N; Bievelez A; Jacot W; Leaha C; Thezenas S; Alix-Panabières C
    Clin Chem; 2022 Oct; 68(10):1311-1322. PubMed ID: 35953885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases.
    Ge M; Zhan Q; Zhang Z; Ji X; Zhou X; Huang R; Liang X
    BMC Cancer; 2019 Feb; 19(1):143. PubMed ID: 30755180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osimertinib Quantitative and Gene Variation Analyses in Cerebrospinal Fluid and Plasma of a Non-small Cell Lung Cancer Patient with Leptomeningeal Metastases.
    Song Y; Liu P; Huang Y; Guan Y; Han X; Shi Y
    Curr Cancer Drug Targets; 2019; 19(8):666-673. PubMed ID: 30332963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.